What question did this study set out to answer?

This research aimed to develop and evaluate a new oral formulation for Lornoxicam.

March 14, 2026Drugs in R&D0 citationsOpen Access

Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam

YLYang LiuCentral Hospital of Wuhan QSQiongzhi ShiCentral Hospital of Wuhan YWYanchen WangXuzhou Medical College

Key Points

This research aimed to develop and evaluate a new oral formulation for Lornoxicam.
Developed biphasic-release multiple-unit tablets (MUTs)
Assessed rapid onset and sustained delivery characteristics
Evaluated dose flexibility in laboratory settings
Biphasic-release MUTs provide rapid onset of action
Enabled sustained delivery of Lornoxicam
Demonstrated reliable dose flexibility for effective therapy

Abstract

The developed biphasic-release MUTs provide rapid onset, sustained LOX delivery, and reliable dose flexibility, representing a promising oral formulation for LOX therapy.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper